Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000209:etiology; D004352:Drug Resistance, Microbial; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
D000995:Antitubercular Agents